Skip to content

Stock Investor News

Stock Market News for the DIY Investor
  • Home
  • About
  • Blog
  • Contact
  • Legals
    • Privacy
    • Terms
    • Data Use
  • GET YOUR FREE REPORT

Stock Investor News

Stock Market News for the DIY Investor
  • Home
  • About
  • Blog
  • Contact
  • Legals
    • Privacy
    • Terms
    • Data Use
  • GET YOUR FREE REPORT

Big Implications From This Big Medical Cannabis Win

  • by Ashley Hayes
  • April 30, 2018February 16, 2021

For the first time ever, a cannabis-based medicine has gotten a favorable recommendation from an advisory panel to the FDA. What does this major win mean for the company (a potential buyout target) behind the drug – and marijuana stocks in general? CLICK HERE.

Tags:Buyout TargetCannabis StocksFDAInvestingInvestmentMarijuana StocksMedical Cannabis InvestmentsMMJ StocksStock Buys

Download Your Free Report

Recent Posts

  • The Single Best Bellwether Stock?
  • 3 Out Of Favor Health Care Stocks To Play This Favorite Investing Theme
  • This Dividend Stock Has Plenty Of Appeal Despite Its Price
  • Count The Reasons To Consider This Discounted Pharma Stock
  • 3 Appetizing Blue Chips With Solid Dividends

Archives

Categories

Stock Investor News

  • About
  • Contact
  • Advertise
  • Write For Us

Support

For questions about any of the Stock Investor News suite of products, please contact our support team info@stockinvestornews.com or call us at 1-855-570-9125

Legals

  • Privacy
  • Terms
  • Disclaimer
  • Data Use

Free Report

Copyright © 2020-2021 Stock Investor News